Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 04:00 ET | Source: XL-protein GmbH

XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters

Freising, Germany, May 28, 2026 (GLOBE NEWSWIRE) -- XL‑protein GmbH today announced the launch of PASylANTA Therapeutics GmbH, a new Germany-based biotechnology company focused on the development of...
May 28, 2026 03:00 ET | Source: Theolytics

Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026

THEO-260 is an oncolytic immunotherapy developed for effective targeting of cancer cells and cancer-associated fibroblasts, whilst inducing immune activation in stroma-rich tumoursUS trial...
May 28, 2026 02:00 ET | Source: Trogenix

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

UK and US trial sites open; first patient dosed with TGX-007, Trogenix’s proprietary dual-payload AAV gene therapyTGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that...
May 28, 2026 01:15 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

US BARDA awarded Basilea USD 13.3 million to continue the development of Basilea’s novel oral antibiotic ceftibuten-ledaborbactam.
May 28, 2026 01:15 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea erhält weitere USD 13 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam

US BARDA hat Basilea USD 13.3 Millionen für die Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam bereitgestellt.
May 28, 2026 01:00 ET | Source: GlobeNewswire, Inc.

Start of Day Message

LONDON, 28 May. 2026 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
May 28, 2026 01:00 ET | Source: Banqup Group SA

Banqup Group announces change at the helm of its management

La Hulpe, Belgium - 28 May 2026, 7:00 CEST - INSIDE INFORMATION - Banqup Group SA (Euronext: BANQ) (Banqup, Company), a leading provider of integrated financial workflow management solutions, today...
May 27, 2026 22:18 ET | Source: Pepeto

Crypto News: Pepeto Presale Stage Sells Out Ahead of Schedule While the XRP Price Prediction Asks if $10 Is Reachable After Record ETF Month

Dubai, UAE, May 27, 2026 (GLOBE NEWSWIRE) -- Pepeto's latest presale stage sold out ahead of schedule and new wallets enter at double last month's rate. This is not attention from paid promotion....
May 27, 2026 18:42 ET | Source: www.textus.com

Business SMS Is No Longer Just a Campaigns Channel — TextUs Builds for the Full SaaS Revenue Funnel

Denver, CO., May 27, 2026 (GLOBE NEWSWIRE) -- TextUs, the leading business text messaging platform for sales, recruiting, and customer engagement teams, is advancing a suite of platform capabilities...
May 27, 2026 17:35 ET | Source: Rocket Doctor AI Inc.

Rocket Doctor AI Announces Global Company Town Hall to Showcase 2025 Milestones; Q1 2026 Milestones and Strategic Vision

Vancouver, BC, May 27, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare...